Gelucire®44/14 improves fat absorption in rats with impaired lipolysis

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1801, Issue 6, 2010, Pages 665-673

  Lukovac, S ^a,b   Gooijert, K E G ^a,b   Gregory, P C ^c   Shlieout, G ^c   Stellaard, F ^a,b   Rings, E H H M ^a,b   Verkade, H J ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

Fat absorption; Gelucire 44 14; Lipolysis; Orlistat; Solubilization

Indexed keywords

CARBON 13; GELUCIRE; PALMITIC ACID; TETRAHYDROLIPSTATIN; FAT; GELUCIRE 44 14; GELUCIRE 44-14; MACROGOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ISOTOPE LABELING; LIPID ABSORPTION; LIPOLYSIS; MALE; MICROEMULSION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; INTESTINE ABSORPTION; METABOLISM; WISTAR RAT;

RATTUS;

ANIMALS; FATS; INTESTINAL ABSORPTION; LIPOLYSIS; MALE; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR;

EID: 77950865347     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2010.03.006     Document Type: Article

References (35)

1. Carey M.C., Small D.M., and Bliss C.M. Lipid digestion and absorption. Annu. Rev. Physiol. 45 (1983) 651-677
2. Bliss C.M. Fat absorption and malabsorption. Arch. Intern. Med. 141 (1981) 1215
3. Quinton P.M. Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet 372 (2008) 415-417
4. Strandvik B., Einarsson K., Lindblad A., and Angelin B. Bile acid kinetics and biliary lipid composition in cystic fibrosis. J. Hepatol. 25 (1996) 43-48
5. Roy C.C., Weber A.M., Morin C.L., Combes J.C., Nussle D., Megevand A., and Lasalle R. Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes. N. Engl. J. Med. 297 (1977) 1301-1305
6. Shumaker H., Amlal H., Frizzell R., Ulrich C.D., and Soleimani M. CFTR drives Na+-nHCO-3 cotransport in pancreatic duct cells: a basis for defective HCO-3 secretion in CF. Am. J. Physiol. 276 (1999) C16-C25
7. Rivers J.P., and Hassam A.G. Defective essential-fatty-acid metabolism in cystic fibrosis. Lancet 2 (1975) 642-643
8. Innis S.M., and Davidson A.G. Cystic fibrosis and nutrition: linking phospholipids and essential fatty acids with thiol metabolism. Annu. Rev. Nutr. 28 (2008) 55-72
9. Symonds E.L., Omari T.I., Webster J.M., Davidson G.P., and Butler R.N. Relation between pancreatic lipase activity and gastric emptying rate in children with cystic fibrosis. J. Pediatr. 143 (2003) 772-775
10. Meyer J.H., Elashoff J.D., and Lake R. Gastric emptying of indigestible versus digestible oils and solid fats in normal humans. Dig. Dis. Sci 44 (1999) 1076-1082
11. Kusoffsky E., Strandvik B., and Troell S. Prospective study of fatty acid supplementation over 3 years in patients with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 2 (1983) 434-438
12. Bronstein M.N., Sokol R.J., Abman S.H., Chatfield B.A., Hammond K.B., Hambidge K.M., Stall C.D., and Accurso F.J. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J. Pediatr. 120 (1992) 533-540
13. Fernandez S., Rodier J.D., Ritter N., Mahler B., Demarne F., Carriere F., and Jannin V. Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases. Biochim. Biophys. Acta 1781 (2008) 367-375
14. Henness S., and Perry C.M. Orlistat: a review of its use in the management of obesity. Drugs 66 (2006) 1625-1656
15. Nishioka T., Hafkamp A.M., Havinga R., vn Lierop P.P., Velvis H., and Verkade H.J. Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats. J. Pediatr. 143 (2003) 327-334
16. Kalivianakis M., Minich D.M., Havinga R., Kuipers F., Stellaard F., Vonk R.J., and Verkade H.J. Detection of impaired intestinal absorption of long-chain fatty acids: validation studies of a novel test in a rat model of fat malabsorption. Am. J. Clin. Nutr. 72 (2000) 174-180
17. Hafkamp A.M., Havinga R., Ostrow J.D., Tiribelli C., Pascolo L., Sinaasappel M., and Verkade H.J. Novel kinetic insights into treatment of unconjugated hyperbilirubinemia: phototherapy and orlistat treatment in Gunn rats. Pediatr. Res. 59 (2006) 506-512
18. Nishioka T., Having R., Tazuma S., Stellaard F., Kuipers F., and Verkade H.J. Administration of phosphatidylcholine-cholesterol liposomes partially reconstitutes fat absorption in chronically bile-diverted rats. Biochim. Biophys. Acta 1636 (2004) 90-98
19. Kuipers F., Havinga R., Bosschieter H., Toorop G.P., Hindriks F.R., and Vonk R.J. Enterohepatic circulation in the rat. Gastroenterology 88 (1985) 403-411
20. Minich D.M., Kalivianakis M., Havinga R., Van G.H., Stellaard F., Vonk R.J., Kuipers F., and Verkade H.J. Bile diversion in rats leads to a decreased plasma concentration of linoleic acid which is not due to decreased net intestinal absorption of dietary linoleic acid. Biochim. Biophys. Acta 1438 (1999) 111-119
21. Muskiet F.A., van Doormaal J.J., Martini I.A., Wolthers B.G., and van der Slik W. Capillary gas chromatographic profiling of total long-chain fatty acids and cholesterol in biological materials. J. Chromatogr. 278 (1983) 231-244
22. Damian F., Blaton N., Naesens L., Balzarini J., Kinget R., Augustijns P., and Van den Mooter G. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. 10 (2000) 311-322
23. Barker S.A., Yap S.P., Yuen K.H., McCoy C.P., Murphy J.R., and Craig D.Q. An investigation into the structure and bioavailability of alpha-tocopherol dispersions in Gelucire 44/14. J. Control Release 91 (2003) 477-488
24. Yuksel N., Karatas A., Ozkan Y., Savaser A., Ozkan S.A., and Baykara T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and labrasol: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 56 (2003) 453-459
25. Fernandez S., Chevrier S., Ritter N., Mahler B., Demarne F., Carriere F., and Jannin V. In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14. Pharm. Res. 26 (2009) 1901-1910
26. Hamid K.A., Katsumi H., Sakane T., and Yamamoto A. The effects of common solubilizing agents on the intestinal membrane barrier functions and membrane toxicity in rats. Int. J. Pharm. 379 (2009) 100-108
27. Fernandez S., Jannin V., Rodier J.D., Ritter N., Mahler B., and Carriere F. Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. Biochim. Biophys. Acta 1771 (2007) 633-640
28. Ferraz R.R., Tiselius H.G., and Heilberg I.P. Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion. Kidney Int. 66 (2004) 676-682
29. Drent M.L., Larsson I., William-Olsson T., Quaade F., Czubayko F., von B.K., Strobel W., Sjostrom L., and van der Veen E.A. Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study. Int. J. Obes. Relat. Metab. Disord. 19 (1995) 221-226
30. Davidson M.H., Hauptman J., DiGirolamo M., Foreyt J.P., Halsted C.H., Heber D., Heimburger D.C., Lucas C.P., Robbins D.C., Chung J., and Heymsfield S.B. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA 281 (1999) 235-242
31. Carriere F., Renou C., Ransac S., Lopez V., De C.J., Ferrato F., De C.A., Fleury A., Sanwald-Ducray P., Lengsfeld H., Beglinger C., Hadvary P., Verger R., and Laugier R. Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers. Am. J. Physiol. Gastrointest. Liver Physiol. 281 (2001) G16-G28
32. Subramanian R., and Wasan K.M. Effect of lipid excipients on in vitro pancreatic lipase activity. Drug Dev. Ind. Pharm. 29 (2003) 885-890
33. Sako N., Okamoto K., Mori T., and Yamamoto T. The hardness of food plays an important role in food selection behavior in rats. Behav. Brain Res. 133 (2002) 377-382
34. Kalivianakis M., Elstrodt J., Havinga R., Kuipers F., Stellaard F., Sauer P.J.J., Vonk R.J., and Verkade H.J. Validation in an animal model of the carbon 13-labeled mixed triglyceride breath test for the detection of intestinal fat malabsorption. J. Pediatr. 135 (1999) 444-450
35. Jorgensen H., Gabert V.M., Hedemann M.S., and Jensen S.K. Digestion of fat does not differ in growing pigs fed diets containing fish oil, rapeseed oil or coconut oil. J. Nutr. 130 (2000) 852-857